MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.
MUC1 is a transmembrane mucin that has been related to tumor progression and outcome in various malignancies. However, the clinical significance in thymic epithelial tumors remains unknown. We investigated the clinical significance of MUC1 expression in thymic epithelial tumors. Fifty-five patients with thymic epithelial tumors were included in this study. Tumors sections were stained by immunohistochemistry for MUC1, vascular endothelial growth factor (VEGF), microvessel density (MVD) determined by CD34, and p53. MUC1 were expressed in 29%. The expression of MUC1 was significantly correlated with the grade of malignancy in thymic epithelial tumors. MUC1 was closely associated with VEGF, p53 and MVD, and the overexpression of MUC1 was a prognostic marker for predicting poor outcome in univariate analysis. A positive rate of MUC1 expression was 94% (16/17) in thymic carcinomas and 0% (0/5) in type B3 thymomas, demonstrating a significant difference (p < 0.0001). The expression of MUC1 was closely related to the grade of malignancy in thymic epithelial tumors. A positive expression of MUC1 was significantly associated with poor outcome in this disease. MUC1 may be useful marker for differentiating thymic carcinoma from type B3 thymoma.
Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi-cho, Sunto-gun, Shizuoka, Japan. kkaira1970@yahoo.co.jp
Kyoichi
K
Kaira
Haruyasu
H
Murakami
Masakuni
M
Serizawa
Yasuhiro
Y
Koh
Masato
M
Abe
Yasuhisa
Y
Ohde
Toshiaki
T
Takahashi
Haruhiko
H
Kondo
Takashi
T
Nakajima
Nobuyuki
N
Yamamoto
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000096:biosynthesis*; D009375:Neoplasms, Glandular and Epithelial / Q000378:metabolism / Q000473:pathology; D013945:Thymoma / Q000378:metabolism* / Q000473:pathology; D013953:Thymus Neoplasms / Q000378:metabolism / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis
D014408:Biomarkers, Tumor; C060192:MUC1 protein, human; D018396:Mucin-1; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A
Pathol Int. 2002 Nov;52(11):713-23
12685548
Cancer Biol Ther. 2009 Jul;8(13):1197-203
19556858
Mol Urol. 1999;3(3):163-168
10851319
J Clin Oncol. 2010 Aug 10;28(23):3746-53
20625125
J Biol Chem. 1990 Sep 5;265(25):15286-93
1697589
Jpn J Clin Oncol. 2002 Dec;32(12):525-9
12578901
J Clin Invest. 1997 Dec 1;100(11):2783-92
9389743
Clin Cancer Res. 2004 Apr 15;10(8):2790-6
15102686
J Gastroenterol. 2003;38(12):1162-6
14714254
Clin Exp Metastasis. 2004;21(4):353-62
15554392
Int J Cancer. 2003 Jul 1;105(4):546-51
12712448
Clin Cancer Res. 1998 Nov;4(11):2605-14
9829723
Hum Pathol. 2008 Jan;39(1):126-36
17949785
J Thorac Oncol. 2006 Jan;1(1):46-51
17409826
Oncogene. 2004 Jul 29;23(34):5739-47
15221004
Int J Mol Med. 2003 Oct;12(4):493-502
12964025
Cancer. 1981 Dec 1;48(11):2485-92
7296496
Mod Pathol. 2009 Oct;22(10):1341-50
19648882
Histopathology. 2002 Jan;40(1):92-100
11903603